SQI Diagnostics Inc V.SQD.H

Technology Scientific & Technical Instruments

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > News Release

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 10, 2021 8:07am

116 Views

Post# 32522568

RE:RE:News Release

I like it

1. it will fill the Company coffers to the tune of about $20M

2. Private transactions will increase the float and improve overall liquidity. The shares need to move from the insiders to institutions and small investors in order to appreciate in value. Hopefully laying the base for much more US buying as well.

Large private transactions or crosses will be a good sign.

A necessary and good first step on the journey.

glta

MM

<< Previous

Bullboard Posts

Next >>

Day trading vs. swing trading strategies for small-cap stocks